These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5212270)

  • 1. Platelet transfusion procedures. Platelet Transfusion Subcommitte of the Acute Leukemia Task Force.
    Cancer Chemother Rep 3; 1968 Dec; 1(1):1-12. PubMed ID: 5212270
    [No Abstract]   [Full Text] [Related]  

  • 2. Current plasmapheresis practices in the United States.
    Crispen JF
    Dev Biol Stand; 1980; 48():297-301. PubMed ID: 7274561
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of commercial plasmapheresis banks on the AIDS epidemic in Mexico.
    Volkow P; Perez-Padilla R; del-Rio C; Mohar A
    Rev Invest Clin; 1998; 50(3):221-6. PubMed ID: 9763887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of repeated plasmapheresis in blood donors].
    Daszyński J; Klenowska Z; Kotelba-Witkowska B; Lewicz I; Rodkiewicz H
    Pol Tyg Lek; 1967 Apr; 22(14):514-6. PubMed ID: 6045885
    [No Abstract]   [Full Text] [Related]  

  • 5. Donor safety in plasmapheresis.
    Lundsgaard-Hansen P
    Dev Biol Stand; 1980; 48():287-95. PubMed ID: 7274560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observation of the changes of plasma proteins after long term plasmapheresis.
    Grgicević D; Pistotnik M; Pende B
    Dev Biol Stand; 1980; 48():279-86. PubMed ID: 6168506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of long-term plasmapheresis on blood coagulation.
    Grgicević D
    Ric Clin Lab; 1983; 13(1):21-31. PubMed ID: 6407088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmapheresis in healthy donors in the Netherlands: cohort study of risk factors for donor complications.
    Wiersum-Osselton JC; Marijt-van der Kreek T; van Dongen R
    Transfus Apher Sci; 2013 Apr; 48(2):163. PubMed ID: 23809816
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of plasmapheresis on platelet hemostatic capacity in healthy voluntary blood donors detected by the platelet function analyzer PFA-100.
    Feuring M; Gutfleisch A; Ganschow A; Richter E; Eichler H; Dempfle CE; Tillmann HC; Schultz A; Wehling M
    Platelets; 2001 Jun; 12(4):236-40. PubMed ID: 11454258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of leukocyte and platelet administration in cancer therapy.
    Walker EM; Cannon A; Mitchum EN
    Ann Clin Lab Sci; 1983; 13(6):453-73. PubMed ID: 6197928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [State of the cardiovascular system in donors undergoing multiple, frequently repeated plasmapheresis].
    Gutnik RB; Iaralova PV; Muravova LP; Kovalkina LA; Khazan LD
    Probl Gematol Pereliv Krovi; 1981 Jan; 26(1):27-9. PubMed ID: 7220517
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
    Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
    Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on blood component transfusion with continuous blood cell separator (IBM 2997). Part 2: methods of granulocyte and platelet harvesting and efficacies of the component transfusion].
    Toki H; Ishikawa M
    Rinsho Ketsueki; 1982 Apr; 23(4):441-8. PubMed ID: 7131790
    [No Abstract]   [Full Text] [Related]  

  • 14. [Education in medical technology increases safety in nursing].
    Roxström C
    Vardfacket; 1992 Feb; 16(3):18-9. PubMed ID: 1636292
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ineffective platelet transfusion with anti-lymphocyte-antibodies--successful bone marrow transplantation following plasmapheresis].
    Taniwaki K; Kai T; Hara Y; Nagai K; Otoshi K
    Rinsho Ketsueki; 1982 Oct; 23(10):1613-7. PubMed ID: 6759699
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasmapheresis operations in the United States--1968.
    Hartney JB
    JAMA; 1970 Aug; 213(6):1023-5. PubMed ID: 5468172
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
    Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
    Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Massive cytopheresis in blood donors].
    Kaliuta BA; Baranov AE; Orekhovskaia AB; Kravtseva RG; Gruzdeva NM
    Probl Gematol Pereliv Krovi; 1976 Dec; 21(12):43-5. PubMed ID: 1024205
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Operation and management of the medical lecture theatre, part 2.
    Lunnon RJ; Ireland RF
    Med Biol Illus; 1977 May; 27(2):63-6. PubMed ID: 70578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.